SMS Lifesciences India successfully completes USFDA inspection at its API facility

SMS Lifesciences India Limited has completed the United States Food and Drug Administration (USFDA) inspection at its API manufacturing facility located at Sy. No. 180/2, Kazipally, Jinnaram Mandal, Sangareddy district, Telangana (Unit I), without any observations.

The inspection commenced on 04.04.2022 and concluded on 08.04.2022.

Shares of SMS Lifesciences India Limited was last trading in BSE at Rs. 789.80 as compared to the previous close of Rs. 777.65. The total number of shares traded during the day was 209 in over 36 trades.

The stock hit an intraday high of Rs. 793.90 and intraday low of 777.00. The net turnover during the day was Rs. 163803.00.

Source : Equity Bulls

Keywords

SMSLifesciencesIndia INE320X01016 USFDA APIFacility ZeroObservations Inspection